|
1
|
Fei YY, Li XM, Lin DF, Li MT, Zhang W, et
al: Importance of salivary gland focus score in the diagnosis of
Sjögren’s syndrome. Zhonghua Yi Xue Za Zhi. 93:976–979. 2013.(In
Chinese).
|
|
2
|
Susić G, Stojanović R, Milić V, Boricić I,
Mandić B and Milenković S: Juvenile Sjögren’s syndrome: case
report. Srp Arh Celok Lek. 141:228–231. 2013.(In Serbian).
|
|
3
|
Igoe A and Scofield RH: Autoimmunity and
infection in Sjögren’s syndrome. Curr Opin Rheumatol. 25:480–487.
2013.
|
|
4
|
Cermak JM, Papas AS, Sullivan RM, Dana MR
and Sullivan DA: Nutrient intake in women with primary and
secondary Sjögren’s syndrome. Eur J Clin Nutr. 57:328–334.
2003.PubMed/NCBI
|
|
5
|
Nocturne G and Mariette X: Advances in
understanding the pathogenesis of primary Sjögren’s syndrome. Nat
Rev Rheumatol. 9:544–556. 2013.
|
|
6
|
Routsias JG, Goules JD, Charalampakis G,
Tzima S, Papageorgiou A and Voulgarelis M: Malignant lymphoma in
primary Sjögren’s syndrome: an update on the pathogenesis and
treatment. Semin Arthritis Rheum. 43:178–186. 2013.PubMed/NCBI
|
|
7
|
Antero DC, Parra AG, Miyazaki FH, Gehlen M
and Skare TL: Secondary Sjögren’s syndrome and disease activity of
rheumatoid arthritis. Rev Assoc Med Bras. 57:319–322. 2011.
|
|
8
|
Kovács L, Szodoray P and Kiss E: Secondary
tumours in Sjögren’s syndrome. Autoimmun Rev. 9:203–206.
2010.PubMed/NCBI
|
|
9
|
Baurmash HD: Diagnosing primary and
secondary Sjögren’s syndrome. J Oral Maxillofac Surg. 62:764–766.
2004.
|
|
10
|
Porola P, Mackiewicz Z, Laine M, Baretto
G, Stegaev V, et al: Laminin isoform profiles in salivary glands in
Sjögren’s syndrome. Adv Clin Chem. 55:35–59. 2011.
|
|
11
|
Busamia B, Gonzalez-Moles MA, Ruiz-Avila
I, Brunotto M, Gil-Montoya JA, et al: Cell apoptosis and
proliferation in salivary glands of Sjögren’s syndrome. J Oral
Pathol Med. 40:721–725. 2011.PubMed/NCBI
|
|
12
|
Porola P, Laine M, Virtanen I, Pöllänen R,
Przybyla BD and Konttinen YT: Androgens and integrins in salivary
glands in Sjögren’s syndrome. J Rheumatol. 37:1181–1187.
2010.PubMed/NCBI
|
|
13
|
Szczerba BM, Rybakowska PD, Dey P,
Payerhin KM, Peck AB, et al: Type I interferon receptor deficiency
prevents murine Sjögren’s syndrome. J Dent Res. 92:444–449.
2013.PubMed/NCBI
|
|
14
|
Nordmark G, Eloranta ML and Ronnblom L:
Primary Sjögren’s syndrome and the type I interferon system. Curr
Pharm Biotechnol. 13:2054–2062. 2012.
|
|
15
|
Mavragani CP and Crow MK: Activation of
the type I interferon pathway in primary Sjögren’s syndrome. J
Autoimmun. 35:225–231. 2010.
|
|
16
|
Feng Y, Liu Z, Peng Y, Zhang L, Ju P, et
al: Validated LC-MS method for simultaneous quantitation of
catalpol and harpagide in rat plasma: application to a comparative
pharmacokinetic study in normal and diabetic rats after oral
administration of Zeng-Ye-Decoction. Biomed Chromatogr.
27:1503–1510. 2013. View
Article : Google Scholar
|
|
17
|
Tang W: Analysis of Warm Diseases. Beijing
People’s Medical Publishing House; Beijing: pp. 641963, (In
Chinese).
|
|
18
|
Primary and secondary Sjögren’s syndrome.
Lancet. 2:730–731. 1984.
|
|
19
|
Amador-Patarroyo MJ, Arbelaez JG, Mantilla
RD, Rodriguez-Rodriguez A, Cárdenas-Roldán J, et al: Sjögren’s
syndrome at the crossroad of polyautoimmunity. J Autoimmun.
39:199–205. 2012.
|
|
20
|
Baldini C, Talarico R, Tzioufas AG and
Bombardieri S: Classification criteria for Sjögren’s syndrome: a
critical review. J Autoimmun. 39:9–14. 2012.
|
|
21
|
Tanner K, Roy N, Merrill RM, Kendall K,
Miller KL, et al: Comparing nebulized water versus saline after
laryngeal desiccation challenge in Sjögren’s Syndrome.
Laryngoscope. 123:2787–2792. 2013.PubMed/NCBI
|
|
22
|
Castro I, Sepulveda D, Cortés J, Quest AF,
Barrera MJ, et al: Oral dryness in Sjögren’s syndrome patients. Not
just a question of water. Autoimmun Rev. 12:567–574. 2013.
|
|
23
|
Wu AJ: The oral component of Sjögren’s
syndrome: pass the scalpel and check the water. Curr Rheumatol Rep.
5:304–310. 2003.
|
|
24
|
Steinfeld S, Cogan E, King LS, Agre P,
Kiss R and Delporte C: Abnormal distribution of aquaporin-5 water
channel protein in salivary glands from Sjögren’s syndrome
patients. Lab Invest. 81:143–148. 2001.PubMed/NCBI
|
|
25
|
Miyawaki S, Torikai K, Natsume I, Nobunaga
T, Ohtsuka E, et al: Evaluation of two quantitative tests for
salivary secretion - the chewing gum test and the Saxon test in
normal subjects and in patients with Sjögren’s syndrome. Ryumachi.
31:22–27. 1991.(In Japanese).
|
|
26
|
van der Reijden WA, van der Kwaak H,
Vissink A, Veerman EC and Amerongen AV: Treatment of xerostomia
with polymer-based saliva substitutes in patients with Sjögren’s
syndrome. Arthritis Rheum. 39:57–63. 1996.PubMed/NCBI
|
|
27
|
Ramos-Casals M, Brito-Zerón P,
Sisó-Almirall A, Bosch X and Tzioufas AG: Topical and systemic
medications for the treatment of primary Sjögren’s syndrome. Nat
Rev Rheumatol. 8:399–411. 2012.
|
|
28
|
Simmons DD, Al-Hashimi I and Haghighat N:
Effect of xerostomic medications on stimulated salivary flow rate
in patients with Sjögren’s syndrome. Quintessence Int. 31:196–200.
2000.PubMed/NCBI
|
|
29
|
Sabapathy K: Role of the JNK pathway in
human diseases. Prog Mol Biol Transl Sci. 106:145–169. 2012.
View Article : Google Scholar : PubMed/NCBI
|
